Placebo + Sevelamer Carbonate (GZ419831)
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperphosphatemia
Conditions
Hyperphosphatemia
Trial Timeline
Jun 7, 2017 → Aug 16, 2019
NCT ID
NCT03001011About Placebo + Sevelamer Carbonate (GZ419831)
Placebo + Sevelamer Carbonate (GZ419831) is a phase 3 stage product being developed by Sanofi for Hyperphosphatemia. The current trial status is completed. This product is registered under clinical trial identifier NCT03001011. Target conditions include Hyperphosphatemia.
What happened to similar drugs?
2 of 14 similar drugs in Hyperphosphatemia were approved
Approved (2) Terminated (0) Active (12)
✅Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapyAkebia TherapeuticsApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03001011 | Phase 3 | Completed |
Competing Products
20 competing products in Hyperphosphatemia